Paper41350360
Dysregulation of HOXA genes in acute myeloid leukemia and targeted therapy.
Huang W and 4 others. NPJ Precis Oncol, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Dysregulation of HOXA genes in acute myeloid leukemia and targeted therapy. Papers, record 41350360. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41350360
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2019YFA0111000 | National Key Research and Development Program of China | PubMed | ||
| 82470166, 82400188, 82200149, 82170158, 82100175 and 82100170 | the National Natural Science Foundation of China | PubMed | ||
| BK20231195, BK20210087 | the priority academic program development of Jiangsu Higher Education Institution, the Natural Science Foundation of Jiangsu Province | PubMed |
Source PubMed
References194
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16507773 | c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. | Blood | 2006 | https://conductscience.org/library/papers/16507773 | PubMed |
| 2 | 34320268 | SET-NUP214 and MLL cooperatively regulate the promoter activity of the HoxA10 gene. | Genes Cells | 2021 | https://conductscience.org/library/papers/34320268 | PubMed |
| 3 | 38358850 | Menin dependence: UBTF-ITD AML joins the club. | Blood | 2024 | https://conductscience.org/library/papers/38358850 | PubMed |
| 4 | 26740045 | Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes. | Elife | 2016 | https://conductscience.org/library/papers/26740045 | PubMed |
| 5 | 23361907 | Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l. | Blood | 2013 | https://conductscience.org/library/papers/23361907 | PubMed |
| 6 | 26615201 | The long noncoding RNA Gm15055 represses Hoxa gene expression by recruiting PRC2 to the gene cluster. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26615201 | PubMed |
| 7 | 9058712 | Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. | Blood | 1997 | https://conductscience.org/library/papers/9058712 | PubMed |
| 8 | 11840284 | Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. | Leukemia | 2002 | https://conductscience.org/library/papers/11840284 | PubMed |
| 9 | 30205049 | Mutant NPM1 Maintains the Leukemic State through HOX Expression. | Cancer Cell | 2018 | https://conductscience.org/library/papers/30205049 | PubMed |
| 10 | 31590682 | Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair. | Clin Epigenetics | 2019 | https://conductscience.org/library/papers/31590682 | PubMed |
| 11 | 29563185 | Structural and functional analysis of the DOT1L-AF10 complex reveals mechanistic insights into MLL-AF10-associated leukemogenesis. | Genes Dev | 2018 | https://conductscience.org/library/papers/29563185 | PubMed |
| 12 | 37055414 | Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. | Blood Cancer J | 2023 | https://conductscience.org/library/papers/37055414 | PubMed |
| 13 | 31978781 | Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library. | Eur J Med Chem | 2020 | https://conductscience.org/library/papers/31978781 | PubMed |
| 14 | 32183947 | It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice. | Cancer Cell | 2020 | https://conductscience.org/library/papers/32183947 | PubMed |
| 15 | 36264143 | A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition. | Cancer Discov | 2023 | https://conductscience.org/library/papers/36264143 | PubMed |
| 16 | 24472025 | High-affinity small-molecule inhibitors of the menin-mixed lineage leukemia (MLL) interaction closely mimic a natural protein-protein interaction. | J Med Chem | 2014 | https://conductscience.org/library/papers/24472025 | PubMed |
| 17 | 32219447 | Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia. | Blood | 2020 | https://conductscience.org/library/papers/32219447 | PubMed |
| 18 | 28202494 | Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions. | J Exp Med | 2017 | https://conductscience.org/library/papers/28202494 | PubMed |
| 19 | 12952893 | Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. | Genes Dev | 2003 | https://conductscience.org/library/papers/12952893 | PubMed |
| 20 | 17327400 | Evidence that the Pim1 kinase gene is a direct target of HOXA9. | Blood | 2007 | https://conductscience.org/library/papers/17327400 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42839017 | CTCF-associated chromatin changes between HOXD1 and HOXD8 contribute to TNBC progression. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42839017 | PubMed |
| 42564089 | Case Report: Acute monocytic leukemia mimicking large-vessel vasculitis on 18F-FDG PET/CT. | Front Immunol | 2026 | https://conductscience.org/library/papers/42564089 | PubMed |
| 42278415 | Menin Inhibition in Acute Myeloid Leukemia: Rewiring Leukemic Transcriptional Networks. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278415 | PubMed |
| 42122138 | Acute Myeloid Leukemias with Alterations of Lysine Methyltransferase 2A (KMT2A): Recent Therapeutic Developments. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122138 | PubMed |
| 42005175 | Sequential Transformation of Polycythemia Vera to Myelofibrosis and KMT2A-Rearranged Acute Myeloid Leukemia Treated With Revumenib: A Rare Case of Clonal Evolution. | Cureus | 2026 | https://conductscience.org/library/papers/42005175 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HOXA@ | 3197 | PubTator's text mining | https://conductscience.org/library/genes/3197 | NCBI Gene |
| KMT2A | 4297 | PubTator's text mining | https://conductscience.org/library/genes/4297 | NCBI Gene |
| MEN1 | 4221 | PubTator's text mining | https://conductscience.org/library/genes/4221 | NCBI Gene |
| NPM1 | 4869 | PubTator's text mining | https://conductscience.org/library/genes/4869 | NCBI Gene |
| NUP98 | 4928 | PubTator's text mining | https://conductscience.org/library/genes/4928 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41350360
GET https://conductscience.org/api/papers/v1/41350360/references?page=2